Novo Nordisk A/S’s blockbuster weight-loss drug Wegovy received Food and Drug Administration approval to treat a serious form of liver disease, beating rival Eli Lilly & Co. to the US market for the ...

The Food and Drug Administration (FDA) has further expanded the U.S. indications of Novo Nordisk’s (NVO) popular weight loss ...

MASLD has become the most common chronic liver disease worldwide. The authors review the features of the disease as well as ...

One of the challenges with liver disease is that it can be a silent threat. In its early stages, it may cause only vague ...

Serious infections significantly increase the mortality risk among adults with chronic liver disease, including those without cirrhosis.

Turmeric is known for its anti-inflammatory properties, but is it bad for your liver? Discover when turmeric supports liver ...

China: A large-scale U.S. analysis has revealed that people living with both type 2 diabetes (T2DM) and chronic kidney ...

Men with cirrhosis have a significantly higher risk for liver-related complications ― particularly hepatocellular carcinoma ― ...

Discover the critical insights from top liver specialist Dr. Saurabh Sethi on liver health, revealing facts about liver ...

Fingernails reflect internal health. Changes in nail color or texture may signal health problems. Pale nails may indicate ...

Novo Nordisk said on Friday the U.S. Food and Drug Administration had granted accelerated approval for its weight-loss drug ...